Back to today’s briefing

Story perspectives

FDA Unveils AI-Powered Reviews Amid Controversy and Doubts

7/5/2025

50 6

Summary

Story summary

The FDA is set to revolutionize drug and medical device reviews by harnessing the power of AI, introducing a large language model called Elsa. However, this move has sparked criticism over possible conflicts of interest with the pharmaceutical industry and doubts about AI's reliability in regulatory oversight, especially after recent staff cuts that threaten the agency's effectiveness.

1 of 1

Story summary

The FDA is set to revolutionize drug and medical device reviews by harnessing the power of AI, introducing a large language model called Elsa. However, this move has sparked criticism over possible conflicts of interest with the pharmaceutical industry and doubts about AI's reliability in regulatory oversight, especially after recent staff cuts that threaten the agency's effectiveness.